Voyager Therapeutics
VYGR
#8271
Rank
โ‚ฌ0.20 B
Marketcap
3,68ย โ‚ฌ
Share price
-1.61%
Change (1 day)
-39.78%
Change (1 year)

Revenue for Voyager Therapeutics (VYGR)

Revenue in 2025 (TTM): โ‚ฌ27.81 Million

According to Voyager Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ26.89 Million. In 2024 the company made a revenue of โ‚ฌ76.87 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ0.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Voyager Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ27.81 M-63.82%
2024 โ‚ฌ76.87 M-66.01%
2023 โ‚ฌ0.22 B493.05%
2022 โ‚ฌ38.13 M15.43%
2021 โ‚ฌ33.03 M-76.26%
2020 โ‚ฌ0.13 B49.3%
2019 โ‚ฌ93.18 M1299.21%
2018 โ‚ฌ6.65 M-21.15%
2017 โ‚ฌ8.44 M-37.52%
2016 โ‚ฌ13.51 M-14.72%
2015 โ‚ฌ15.85 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA